Cargando…

Correction: Current status of therapeutic monoclonal antibodies against SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Kumar, Sanjeev, Chandele, Anmol, Sharma, Amit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678312/ https://www.ncbi.nlm.nih.gov/pubmed/36409672 http://dx.doi.org/10.1371/journal.ppat.1010983

Ejemplares similares

Current status of therapeutic monoclonal antibodies against SARS-CoV-2
por: Kumar, Sanjeev, et al.
Publicado: (2021)

Profiles of host immune impairment in Plasmodium and SARS-CoV-2 infections
por: Chaturvedi, Rini, et al.
Publicado: (2022)

Structural Profiles of SARS-CoV-2 Variants in India
por: Chakraborti, Soumyananda, et al.
Publicado: (2022)

Broadly Neutralizing Antibodies to SARS-CoV-2 Provide Novel Insights Into the Neutralization of Variants and Other Human Coronaviruses
por: Bajpai, Prashant, et al.
Publicado: (2022)

Correction: Quantitative Assessment of Antibody Internalization with Novel Monoclonal Antibodies against Alexa Fluorophores
Publicado: (2015)

Correction: Quantitative Assessment of Antibody Internalization with Novel Monoclonal Antibodies against Alexa Fluorophores
Publicado: (2015)

Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection
por: Wang, Chunyan, et al.
Publicado: (2020)

Correction: Immune Response to Dengue Virus Infection in Pediatric Patients in New Delhi, India—Association of Viremia, Inflammatory Mediators and Monocytes with Disease Severity
por: Singla, Mohit, et al.
Publicado: (2016)

Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives
por: Quiros-Roldan, Eugenia, et al.
Publicado: (2021)

Correction: Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins
por: Emmenegger, Marc, et al.
Publicado: (2022)

Correction to: In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies
por: Patel, Ami, et al.
Publicado: (2020)

Monoclonal antibody therapies against SARS-CoV-2
por: Focosi, Daniele, et al.
Publicado: (2022)

Optimization of Flow-Cytometry Based Assay for Measuring Neutralizing Antibody Responses against Each of the Four Dengue Virus Serotypes
por: Sharma, Pragati, et al.
Publicado: (2021)

Double lock of a potent human therapeutic monoclonal antibody against SARS-CoV-2
por: Zhu, Ling, et al.
Publicado: (2020)

Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2
por: Huang, Kuan-Ying A., et al.
Publicado: (2022)

Author Correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
por: Xu, Xin, et al.
Publicado: (2020)

Production and Characterization of Monoclonal Antibodies Against the Nucleocapsid Protein of SARS-COV
por: Fang, Ying, et al.
Publicado: (2006)

Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
por: Tran, Trung The, et al.
Publicado: (2023)

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2
por: Xie, Jiajia, et al.
Publicado: (2021)

ZRC3308 Monoclonal Antibody Cocktail Shows Protective Efficacy in Syrian Hamsters against SARS-CoV-2 Infection
por: Yadav, Pragya D., et al.
Publicado: (2021)

Correction to: Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2
por: Niranjan, Vidya, et al.
Publicado: (2022)

Correction: A Conformation-Sensitive Monoclonal Antibody against the A2 Domain of von Willebrand Factor Reduces Its Proteolysis by ADAMTS13
por: Zhang, Jingyu, et al.
Publicado: (2011)

In-Silico Analysis of Monoclonal Antibodies against SARS-CoV-2 Omicron
por: Hu, Ye-Fan, et al.
Publicado: (2022)

Correction: Breadth and function of antibody response to acute SARS-CoV-2 infection in humans
por: Huang, Kuan-Ying A., et al.
Publicado: (2021)

Correction: Development of a Mouse Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis in Humans
por: Müller, Thomas, et al.
Publicado: (2009)

Correction: Identification and Structural Characterization of Interneurons of the Drosophila Brain by Monoclonal Antibodies of the Würzburg Hybridoma Library
por: Blanco Redondo, Beatriz, et al.
Publicado: (2013)

Correction: Novel in vitro booster vaccination to rapidly generate antigen-specific human monoclonal antibodies
por: Nandin, Irene Sanjuan, et al.
Publicado: (2017)

Author Correction: Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers
por: Marot, Stéphane, et al.
Publicado: (2021)

Correction for Xiong et al., The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2
Publicado: (2022)

Potent Molecular Feature-based Neutralizing Monoclonal Antibodies as Promising Therapeutics Against SARS-CoV-2 Infection
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2021)

The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants
por: Makdasi, Efi, et al.
Publicado: (2021)

Correction: Generation and Improvement of Effector Function of a Novel Broadly Reactive and Protective Monoclonal Antibody against Pneumococcal Surface Protein A of Streptococcus pneumoniae
por: Kristian, Sascha A., et al.
Publicado: (2017)

Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies
por: Yamasoba, Daichi, et al.
Publicado: (2022)

Correction: Saratale et al. Significance of Immune Status of SARS-CoV-2 Infected Patients in Determining the Efficacy of Therapeutic Interventions. J. Pers. Med. 2022, 12, 349
por: Saratale, Ganesh Dattatraya, et al.
Publicado: (2022)

Correction to: Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054
por: Li, Yiwen, et al.
Publicado: (2018)

Correction: Protective porcine influenza virus-specific monoclonal antibodies recognize similar haemagglutinin epitopes as humans
por: Holzer, Barbara, et al.
Publicado: (2021)

Correction: A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2
por: Kim, Gyoung Nyoun, et al.
Publicado: (2022)

Tackling COVID-19 with neutralizing monoclonal antibodies
por: Corti, Davide, et al.
Publicado: (2021)

Author Correction: An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis
por: Krishnananthasivam, Shivankari, et al.
Publicado: (2023)

In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
por: Diamond, Michael, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vigkfmgjbe2ep78e5s957snojb